Japan approved the world's first stem cell therapy for severe heart failure using iPSC technology ReHeart, the iPSC-based product, offers regenerative treatment by repairing damaged heart muscle Clinical trials showed improved symptoms and exercise tolerance in 7 to 8 patients treated
